InnoCan Pharma (TSE:INNO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Innocan Pharma has reported positive outcomes from a long-term compassionate therapy study where dogs with osteoarthritis experienced significant pain relief and mobility improvement after receiving liposomal-CBD (LPT-CBD) injections. The therapy could offer a non-opioid alternative for chronic pain management in animals, and potentially humans, with sustained effects lasting several weeks per dose.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.